148047-03-4

Basic information

• Product Name: 3-[(3,5-di-tert-butyl-4-hydroxyphenyl)sulfanyl]-N-methyl-N-[2-(pyridin-2-yl)ethyl]propanamide hydrochloride (1:1)
• Synonyms: Propanamide, 3-((3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)thio)-N-methyl-N-(2-(2-pyridinyl)ethyl)-, monohydrochloride
• CAS NO: 148047-03-4
• Molecular Formula: C₂₅H₃₇ClN₂O₂S
• Molecular Weight: 465.0915
• Mol File: 148047-03-4.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 539.8°C at 760 mmHg
• Flash Point: 280.2°C
• Vapor Pressure: 2.9E-12mmHg at 25°C
• CAS DataBase Reference: 3-[(3,5-di-tert-butyl-4-hydroxyphenyl)sulfanyl]-N-methyl-N-[2-(pyridin-2-yl)ethyl]propanamide hydrochloride (1:1)(CAS DataBase Reference)
• NIST Chemistry Reference: 3-[(3,5-di-tert-butyl-4-hydroxyphenyl)sulfanyl]-N-methyl-N-[2-(pyridin-2-yl)ethyl]propanamide hydrochloride (1:1)(148047-03-4)
• EPA Substance Registry System: 3-[(3,5-di-tert-butyl-4-hydroxyphenyl)sulfanyl]-N-methyl-N-[2-(pyridin-2-yl)ethyl]propanamide hydrochloride (1:1)(148047-03-4)

Safety Data

• Hazardous Substances Data: 148047-03-4(Hazardous Substances Data)

Relevant articles and documents

Method of stimulating superoxide generation

The present invention is directed to a method of stimulating superoxide generation using phenolic thioethers which stimulate the generation of superoxide.

Acylaminoalkylpyridines ad use in treatment of inflammation and allergy reactions

The compounds of this invention are acylaminoalkylpyridines representd by the formula STR1 wherein: R1 and R2 are the same or different members of the group consisting of halo, phenyl, substituted phenyl and a STR2 group wherein n, m and p are independently an integer of from 1 to 8 provided n+m+p is equal to or less than 10; X is thio, sulfinyl or sulfonyl; Alk1 is straight or branched chain lower alkylene of 1 to 6 carbon atoms, R3 is lower alkyl, Alk2 is straight or branched chain alkylene of 1 to 4 carbon atoms; R4 is selected from the group consisting of hydrogen, halo, hydroxy, lower alkyl and lower alkoxy; and the pharmaceutically acceptable salts thereof. The compounds of the present invention are useful in the treatment of inflammation, allergy and hypersensitivity reactions and other disorders of the immune system.